The new era in cancer research

被引:241
作者
Varmus, Harold [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1126/science.1126758
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
For many years, discoveries about the genetic determinants of cancer appeared to be having only minor effects on efforts to control the disease in the clinic. Following advances made over the past decade, however, a description of cancer in molecular terms seems increasingly likely to improve the ways in which human cancers are detected, classified, monitored, and treated. Achieving the medical promise of this new era in cancer research will require a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic, as well as political, social, and cultural changes.
引用
收藏
页码:1162 / 1165
页数:6
相关论文
共 38 条
[11]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[12]   Annual report to the Nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment [J].
Edwards, BK ;
Brown, ML ;
Wingo, PA ;
Howe, HL ;
Ward, E ;
Ries, LAG ;
Schrag, D ;
Jamison, PM ;
Jemal, A ;
Wu, XC ;
Friedman, C ;
Harlan, L ;
Warren, J ;
Anderson, RN ;
Pickle, LW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (19) :1407-1427
[13]   CTLA-4: new insights into its biological function and use in tumor immunotherapy [J].
Egen, JG ;
Kuhns, MS ;
Allison, JP .
NATURE IMMUNOLOGY, 2002, 3 (07) :611-618
[14]   Reversibility of oncogene-induced cancer [J].
Felsher, DW .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (01) :37-42
[15]   Angiogenesis as a therapeutic target [J].
Ferrara, N ;
Kerbel, RS .
NATURE, 2005, 438 (7070) :967-974
[16]   Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes [J].
Fisher, GH ;
Wellen, SL ;
Klimstra, D ;
Lenczowski, JM ;
Tichelaar, JW ;
Lizak, MJ ;
Whitsett, JA ;
Koretsky, A ;
Varmus, HE .
GENES & DEVELOPMENT, 2001, 15 (24) :3249-3262
[17]   Hereditary cancer predisposition syndromes [J].
Garber, JE ;
Offit, K .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (02) :276-292
[18]   Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification [J].
Gorre, ME ;
Mohammed, M ;
Ellwood, K ;
Hsu, N ;
Paquette, R ;
Rao, PN ;
Sawyers, CL .
SCIENCE, 2001, 293 (5531) :876-880
[19]   Use of gene expression profiling to direct in vivo molecular imaging of lung cancer [J].
Grimm, J ;
Kirsch, DG ;
Windsor, SD ;
Kim, CFB ;
Santiago, PM ;
Ntziachristos, V ;
Jacks, T ;
Weissleder, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (40) :14404-14409
[20]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70